SMS Pharmaceuticals Ltd — Capital/Financing Update 2025

Sep 10, 2025

==> picture [241 x 158] intentionally omitted <==

Date: 10[th] September, 2025

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Symbol: SMSPHARMA

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Allotment of 50,00,000 Equity Shares pursuant to exercise of Warrants allotted on preferential basis

This is in furtherance to our letters dated on 19th March, 2024 & 27[th] March, 2025 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”), we hereby inform you that the Securities Allotment Committee of the Board of Directors of SMS Pharmaceuticals Limited (“the Company”) at its meeting held today i.e. 10[th] September, 2025 has allotted 50,00,000 equity shares of face value of Re.1/- each, on conversion of 50,00,000 Warrants to the Allottees, upon receipt of the balance amount aggregating to Rs. 47,62,50,000 (Forty-Seven Crores Sixty-Two Lakhs Fifty Thousand Only) at the rate of Rs.95.25/- (Rupees Ninety-Five Rupees and Twenty-Five Paise Only) per Warrant (being 75% of the Issue Price per Warrant) pursuant to the exercise of their rights of conversion of Warrants into equity shares in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as per the details given in Annexure I.

These equity shares allotted on conversion of the warrants, shall rank pari-passu in all respects with the existing equity shares of the Company.

Consequent to the said allotment, all the warrants were converted into equity shares and the paid up share capital of the Company stands increased to Rs. 9,36,52,030/- divided into 9,36,52,030 equity shares of face value of Re. 1/- each from Rs.8,86,52,030/- divided into 8,86,52,030 equity shares of face value of Re.1/- each.

==> picture [241 x 158] intentionally omitted <==

Disclosures under Regulation 30 of SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 ("SEBI Circular”), are provided in ‘Annexure II’.

You are requested to take the above information on records.

Thanking you

Yours Faithfully

For SMS Pharmaceuticals Limited

THIRUMALES Digitally signed by THIRUMALESH TUMMA H TUMMA Date: 2025.09.10 18:29:48 +05'30' Thirumalesh Tumma Company Secretary

==> picture [241 x 158] intentionally omitted <==

Annexure I

List of Allottees :

Name of the Allottees	No. of Warrants held	No. of equity shares of face value of Re.1/- each allotted, upon conversion/ exchange of Warrants	No. of warrants outstanding for Conversion
Mr. Vamsi Krishna Potluri	25,00,000	25,00,000	-
Mr. Trilok Potluri	25,00,000	25,00,000	-
Total	50,00,000	50,00,000	-

==> picture [241 x 158] intentionally omitted <==

Annexure II

The details as required under Regulation 30 of SEBI Listing Regulations read with SEBI Circular are as under:

Sl. No	Particulars	Description
1	Type of securities issued	Equity Shares pursuant to exercise of warrants.
2	Type of issuance	Preferential allotment
3	Total number of securities issued or the total amount for which the securities issued (approximately)	Allotment of 50,00,000 Equity Shares of face value of Re. 1/- each upon exercise of equal number of Warrants at an issue price of Rs. 127/-each (including a Premium of Rs.126/-) upon receipt of balance consideration of Rs. 95.25/- per warrant (being 75% of the Warrant Issue Price) aggregating to Rs. 47,62,50,000 (Forty-Seven Crores Sixty- Two Lakhs FiftyThousand Only)
	Additional information in case of preferential issue:
4	Name of the Allottee	As per Annexure-I
5	Post allotment of securities Outcome of the subscription, Issue price / allotted price (in case of convertibles),	As per Annexure-I Pursuant to this allotment, the paid up share capital of the Company stands increased to Rs. 9,36,52,030/- consisting of 9,36,52,030 equity shares of Re. 1/- each. 90,00,000 convertible warrants were allotted on 19th March 2024 at an issue price of Rs.127/- per warrant, carrying a right to subscribe to 1 Equity Share per warrant on receipt of amount at the rate of Rs. 31.75/- per warrant (being 25% of the issue price per warrant). 40,00,000 warrants were converted into equity shares on 27thMarch 2025. The remaining 50,00,000 warrants were converted into 50,00,000 Equity Shares on 10thSeptember 2025, on receipt of balance amount at the rate of Rs. 95.25/- per warrant (being 75% of the issue price per warrant.)

==> picture [241 x 158] intentionally omitted <==

	Number of investors	The option of Conversion exercised by two warrant holders
6	In case of convertibles - intimation on conversion of securities or on lapse of the tenure of the instrument;	Equity shares are being allotted upon exercise of Warrants.